Pioglitazone-Metformin Combination Treatment for High Risk Oral Preneoplasia

Condition:   Oral Leukoplakia Intervention:   Drug: pioglitazone-metformin Sponsor:   University of Minnesota Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Actos | Fortamet | Metformin | Research